Navigation Links
Lung cancer conference leaders honor Paul A. Bunn Jr., M.D.
Date:1/14/2010

CORONADO, Calif. The American Association for Cancer Research and the International Association for the Study of Lung Cancer (IASLC) honored Paul A. Bunn Jr., M.D., for his leadership in lung cancer research at the first Molecular Origins of Lung Cancer conference this week. The conference, held from Jan. 11-14, 2010, drew more than 300 people from around the world. Bunn is professor of medicine and the James Dudley chair in cancer research at the University of Colorado, Denver.

"Dr. Bunn has been an inspiration to physicians and scientists working in the field of lung cancer. He deserves this award for everything that he has contributed to this important field past, present and future," said conference co-chairperson Roy Herbst, M.D., Ph.D., chief of the section of thoracic medical oncology at The University of Texas M. D. Anderson Cancer Center.

Conference co-chairperson David Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research and director of the Specialized Program of Research Excellence in Lung Cancer at Vanderbilt-Ingram Cancer Center, concurred.

"Indeed, Bunn has done much to teach the next generation of scientists and clinicians about excellence in cancer research and treatment," said Carbone.

Bunn, a co-chairperson of the conference, said the combined efforts of the AACR and IASLC have helped to raise awareness of translational research.

"The AACR has been the leader in basic research for many years, and the IASLC has led the way in the clinical arena," said Bunn. "The joining of these two associations for this meeting is a strong indication of how important translational research has become for lung cancer and many other forms of cancer as well."

Lung cancer kills more people than breast, prostate, kidney, colon, liver and skin cancers combined. It is a critical area for future research, according to Bunn.

"Despite its prevalence and the terrible toll that lung cancer takes in terms of human life and suffering, this disease has not been well funded and has not been the focus of as much advocacy as some other cancers," Bunn said. "This is changing. This is a time when there is genuine new hope and optimism for improving the prognosis and quality of life for lung cancer patients."


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert  

Related medicine news :

1. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
2. The first map of colon cancer in Spain is published
3. Stress on Cells Can Turn Them Cancerous
4. Capital BlueCross and P4 Healthcare Launch Cancer Pathways Initiative
5. Therapy May Relieve Breast Cancer Surgery Complication
6. Strides Made in Lung Cancer Treatment
7. Radon Gas Identified as Americas Leading In-Home Killer; EPA Takes Action to Prevent 20,000 U.S. Cancer Deaths Each Year
8. St. Helena Hospital Cancer Center Affiliates with the UCSF Medical Center to Enhance Local Cancer Care
9. The Foundation for Biomedical Research Releases New Breast Cancer PSA
10. Combo PET-CT Scans Can Spot Hidden Cancers
11. Alzheimers Drug Might Help Prevent Esophageal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung cancer conference leaders honor Paul A. Bunn Jr., M.D.
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: